---
title: EvlaBio
date: 2025-07-09T13:38:45Z
modified: 2026-08-11T10:06:07Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/evlabio/"
type: portfolio
status: publish
excerpt: ""
wpid: 124336
language:
  - English
post_translations:
  - pll_6867a29304c7b
branchen22:
  - Cardiology / Cardiovascular
sectors:
  - Pharmaceuticals
focus_areas:
  - Cardiology
timestamp: 2026-08-11T10:06:07Z
tags:
  - English
  - pll_6867a29304c7b
  - Cardiology / Cardiovascular
  - Pharmaceuticals
  - Cardiology
---

## Beschreibungstext Überschrift

EvlaBio

## Beschreibungstext

EvlaBio is a life science company focused on developing first-in-class therapeutics for cardiovascular and cardiorenal diseases. Its lead program targets the FGFR4/FGF23 signaling axis, a critical driver of cardiac remodeling in chronic kidney disease. By advancing novel mechanisms grounded in strong translational science, EvlaBio aims to redefine treatment paradigms for CKD patients with high unmet medical need.

## Unternehmenswebsite

https://evlabio.com/

## Adresse

EvlaBio GmbH
c/o ARQIS, Breite Straße 28
40213 Düsseldorf